Biological E to make 50 million doses of Takeda’s dengue vaccine QDENGA
Takeda and Biological E Limited have partnered to manufacture up to 50 million doses per year of the dengue vaccine QDENGA, with the goal of delivering 100 million doses by 2030. The collaboration aims to make the vaccine widely accessible and combat dengue on a global scale.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
